Assignee
SHAPERON INC
KR·1 granted patent·11 pending applications·0 citations·filing 2017–2024
Top patents by PatentIndex Score
12 records- 0161US2025084170A1Bispecific humanized single domain antibody to pd-l1 and cd47, and use thereofSHAPERON INC·Filed 2024·Application pending·0 cites
- 0259US2025099487A1Composition for preventing or treating pulmonary fibrosis, comprising taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredientSHAPERON INC·Filed 2024·Application pending·0 cites
- 0352US2025134909A1Gel composition for prevention or treatment of atopic dermatitisSHAPERON INC·Filed 2022·Application pending·0 cites
- 0452US2025134910A1Composition for treating coronavirus disease 2019 (covid-19) containing taurodeoxycholic acid or pharmaceutically acceptable salt thereof and antiviral agent as active ingredientsSHAPERON INC·Filed 2022·Application pending·0 cites
- 0551US2025000877A1Composition containing taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredient for preventing or treating viral infectious diseasesSHAPERON INC·Filed 2022·Application pending·0 cites
- 0649US2024391948A1Novel compound that inhibits tnf-alpha generation and inflammasome activity and preparation method thereforSHAPERON INC·Filed 2022·Application pending·0 cites
- 0749US2025262225A1Composition for treatment of covid-19 comprising taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredientSHAPERON INC·Filed 2022·Application pending·0 cites
- 0848US9855283B2Composition comprising GPCR19 agonist as an active ingredient for preventing or treating allergic dermatitisSHAPERON INC·Filed 2017·Granted Jan 2, 2018·0 cites·11 claims
- 0948US2024228670A9Bispecific single domain antibody to pd-l1 and cd47 and use thereofSHAPERON INC·Filed 2022·Application pending·0 cites
- 1047US2024228622A9Single domain antibody against pd-l1 and use thereofSHAPERON INC·Filed 2022·Application pending·0 cites
- 1147US2024228613A9Single domain antibody against cd47 and use thereofSHAPERON INC·Filed 2022·Application pending·0 cites
- 1240US2021386761A1Composition for preventing or treating inflammatory bowel disease, containing, as active ingredient, taurodeoxycholic acid or pharmaceutically acceptable salt thereofSHAPERON INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHAPERON INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →